TJ Musholt, PB Musholt, N Khaladj, D Schulz… - Surgery, 2000 - infona.pl
Background. The expression of RET/PTC chimeras was demonstrated in 10% to 20% of sporadic papillary thyroid carcinomas (PTCs), whereas rearrangements ofNTRK 1 were …
TJ Musholt, PB Musholt, N Khaladj… - British Journal of …, 2000 - Wiley Online Library
Background The genetic background of papillary thyroid carcinoma (PTC) has been elucidated by the identification of somatic translocations of the tyrosine kinases RET and …
TJ Musholt, PB Musholt, N Khaladj, D Schulz… - Surgery, 2000 - surgjournal.com
Background. The expression of RET/PTC chimeras was demonstrated in 10% to 20% of sporadic papillary thyroid carcinomas (PTCs), whereas rearrangements of NTRK1 were …
Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
TJ Musholt, PB Musholt, N Khaladj, D Schulz… - Surgery, 2000 - cir.nii.ac.jp
Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
TJ Musholt, PB Musholt, N Khaladj… - British Journal of …, 2000 - search.ebscohost.com
Background: The genetic background of papillary thyroid carcinoma (PTC) has been elucidated by the identification of somatic translocations of the tyrosine kinases RET and …
TJ Musholt, PB Musholt, N Khaladj… - Journal of British …, 2000 - academic.oup.com
Background Expression of thyroid-specific proteins such as thyroglobulin is controlled by several transcription factors. Thyroid transcription factor (TTF) 2 is the most recently …
TJ Musholt, PB Musholt, N Khaladj, D Schulz… - …, 2000 - pubmed.ncbi.nlm.nih.gov
Background The expression of RET/PTC chimeras was demonstrated in 10% to 20% of sporadic papillary thyroid carcinomas (PTCs), whereas rearrangements of NTRK1 were …
TJ Musholt, PB Musholt, N Khaladj, D Schulz… - Surgery, 2000 - europepmc.org
Background The expression of RET/PTC chimeras was demonstrated in 10% to 20% of sporadic papillary thyroid carcinomas (PTCs), whereas rearrangements of NTRK1 were …